Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mohamed A Ragheb

7PUBLICATIONS
13CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMetal organic frameworksMain group metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|May 19, 2026
Synthesis, computational studies, and biological evaluation of novel cyanoacrylamides as potential anticancer agents.

|Nov 10, 2025
Novel Cyanoacrylamides Incorporating Sulfamethoxazole as Potential Anticancer Agents: DNA Interaction, Apoptotic Induction, and S‑Phase Cell Cycle Arrest in Colon Cancer Cells.

Mohamed A Ragheb, Mostafa E Salem, Mona M Ali

|Feb 05, 2024
Novel Bis(2-cyanoacrylamide) Linked to Sulphamethoxazole: Synthesis, DNA Interaction, Anticancer, ADMET, Molecular Docking, and DFT Studies.

Mohamed A Ragheb, Fatma G Mohamed, Hadeer M Diab

|Aug 31, 2022
Hantzsch-Like Synthesis, DNA Photocleavage, DNA/BSA Binding, and Molecular Docking Studies of Bis(sulfanediyl)bis(tetrahydro-5-deazaflavin) Analogs Linked to Naphthalene Core.

Mohamed A Ragheb, Reham E Abdelwahab, Ahmed F Darweesh

|Apr 15, 2022
Oxidative DNA cleavage mediated by a new unexpected [Pd(BAPP)][PdCl<sub>4</sub>] complex (BAPP = 1,4-bis(3-aminopropyl)piperazine): crystal structure, DNA binding and cytotoxic behavior.

Mona S Ragab, Mohamed R Shehata, Mohamed M Shoukry

|Oct 14, 2021
Light-activated cytotoxicity of dicarbonyl Ru(II) complexes with a benzimidazole coligand towards breast cancer.

Nourhan M Ibrahim, Rabaa M Khaled, Mohamed A Ragheb

Pageof 2

Frequent Collaborators

4 joint publications

Ismail A Abdelhamid

2 joint publications

Rabaa M Khaled

2 joint publications

Ahmed M Mansour

2 joint publications

Ahmed H M Elwahy

1 joint publications

Alexandra Friedrich

1 joint publications

Nour T Abdel-Ghani

1 joint publications

Krzysztof Radacki

1 joint publications

Ahmad M Farag

1 joint publications

Mona S Ragab

1 joint publications

Mohamed R Shehata

Frequent Collaborators

4 joint publications

Ismail A Abdelhamid

2 joint publications

Rabaa M Khaled

2 joint publications

Ahmed M Mansour

2 joint publications

Ahmed H M Elwahy